PHARMACY

Takeda’s ad campaign for Actos emphasizes its heart safety vs. competitor

BY Drew Buono

OSAKA, Japan Takeda is conducting a new ad campaign aimed at showing the cardiovascular safety of its type 2 diabetes medication, Actos. This comes in response to the recent announcement made by the Food and Drug Administration that Avandia, GlaxoSmithKline’s type 2 diabetes medication would be labeled with a warning about heart-attack risks.

The ad will run in 82 daily newspapers and four weekly magazines in the next few weeks, including Newsweek, Time, U.S. News & World Report, People, the Chicago Tribune, The New York Times and the Los Angeles Times, according to Elissa Johnsen, manager of product public relations for Takeda Pharmaceuticals North America.

“Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke,” according to the ads. The message shows a purple ribbon saying Actos is the “#1 prescribed brand-name diabetes medication.”

Sales of Avandia in the U.S. have plunged by about 50 percent since May, when the Cleveland Clinic in Ohio tied it to a 43 percent increased risk of heart attacks in a study. Actos sales, on the other hand, have soared, making it the world’s best-selling diabetes pill and generating $1.87 billion in the six months ended Sept. 30.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Diamyd partners with NIH diabetes group in type 1 vaccine trial

BY Drew Buono

STOCKHOLM, Sweden Diamyd Medical and the National Institute of Diabetes and Kidney Diseases have joined together to initiate a clinical trial with Diamyds’ GAD-alum diabetes vaccine. The clinical trial will involve 126 new onset type 1 diabetes patients. The NIDDK-sponsored consortium type 1 diabetes TrialNet will conduct the clinical study.

The trial will include extensive immunological studies to clarify the mechanism of action and to evaluate the correlation between the clinical and immunological outcomes of GAD-alum Diamyd treatment in recent onset type 1 diabetes patients. The detailed analysis may provide important information into the ability of Diamyd to protect islet cells from autoimmune attack as an instrument for maintaining insulin production. Additionally, the immunological data may prove beneficial for designing future diabetes prevention studies.

“We are extremely excited to be working with NIDDK and TrialNet on this new Diamyd clinical study,” stated Anders Essen-Moller, chief executive officer of Diamyd Medical. “TrialNet is uniquely positioned to conduct clinical studies and to evaluate the molecular and cellular mechanisms of potential diabetes therapies. The insights expected from this trial should prove very valuable for Diamyd, the scientific community and for diabetes patients.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Take Care clinics offer flu shots for CDC’s National Influenza Vaccination Week

BY Allison Cerra

CONSHOHOCKEN, Pa. Take Care Health Systems is set to bring awareness to local communities by offering flu shots in honor of the Centers for Disease Control and Prevention’s National Influenza Vaccination Week from Nov. 26 to Dec. 2.

Dubbed one of the largest convenient retail clinic managers in the United States, and a wholly-owned subsidiary of Walgreens, Take Care is stocked with the immunization, and will offer flu shots every day of the week at all of its 102 locations. The flu shot costs $24.99 and is covered by most insurance providers.

According to the CDC, each year an average of 5 to 20 percent of the U.S. population contracts the flu, more than 200,000 people are hospitalized for flu complications and 36,000 die from it.

Additionally, the CDC’s Advisory Committee on Immunization Practices recommends that the influenza vaccine be offered throughout the entire flu season, even after it has appeared or begun appearing in a community. It takes two weeks after the vaccination for the body to be fully prepared to protect against the flu.

“Annual vaccination is the most effective way to prevent the flu and is best performed early in the season, which can last as late as May,” said Sandra Ryan, chief nurse practitioner officer for Take Care Health Systems. “Take Care Health Clinics, which are open seven days a week with no appointments and accept most major insurance plans, offer an accessible, convenient and affordable way for individuals to protect themselves and their loved ones against the flu this year.”

Though Take Care Health Clinics are dedicated to immunizing local communities from the flu, the professionals at the retail clinics also treat patients 18 months and older for common illnesses, offer diagnostic screenings and write prescriptions.

Take Care Health Systems manages 102 locations in 11 states, including Atlanta, Chicago, Cincinnati and Houston.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?